Literature DB >> 12879434

Compound heterozygosity for two novel mutations in a severe factor XI deficiency.

Akiko Tsukahara1, Takayuki Yamada, Akira Takagi, Takashi Murate, Tadashi Matsushita, Hidehiko Saito, Tetsuhito Kojima.   

Abstract

We identified two novel mutations in an asymptomatic 25-year-old Japanese patient with severe factor XI deficiency. Direct sequencing analysis of PCR products from his factor XI gene revealed a G to T transversion in exon 12, resulting in the nonsense mutation (Glu447Stop) and a G insertion in five consecutive guanine nucleotides ((501)Trp(TGG)-(502)Gly(GGG)) in exon 13 that is expected to lead to the substitution of the last 105 amino acids ((503)Tyr-(607)Val) with 32 abnormal amino acid residues ((503)Val-(534)Thr) followed by stop codon. We also demonstrated that two mutations are associated with the separate alleles in this patient, indicating compound heterozygosity for these mutations. Both mutations lead to the disruption of the catalytic domain structure of the FXI molecule and thus are responsible for his deficiency of factor XI. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879434     DOI: 10.1002/ajh.10378

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Recurrent mutations of factor XI gene in Japanese.

Authors:  Kaoru Okumura; Mayu Kyotani; Reiko Kawai; Akira Takagi; Takashi Murate; Koji Yamamoto; Junki Takamatsu; Tadashi Matsushita; Hidehiko Saito; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

2.  Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations.

Authors:  Akira Takagi; Ryoko Tanaka; Daisuke Nakashima; Yuta Fujimori; Takayuki Yamada; Kaoru Okumura; Takashi Murate; Midori Yamada; Yasuo Horikoshi; Koji Yamamoto; Akira Katsumi; Tadashi Matsushita; Tomoki Naoe; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2009-04-17       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.